RAPT Therapeutics, Inc. (RAPT) Entity Common Stock, Shares Outstanding 2019 - 2024

Historical data

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
RAPT Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from 2019 to 2024.
  • RAPT Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 4, 2024 was 34.8 M shares, a 1.49% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 34.8 M +511 K +1.49% Mar 4, 2024 10-K 2024-03-07
Q3 2023 34.4 M +4.49 M +15% Nov 7, 2023 10-Q 2023-11-13
Q2 2023 34.4 M +4.7 M +15.9% Aug 3, 2023 10-Q 2023-08-11
Q1 2023 34.3 M +4.71 M +15.9% Mar 3, 2023 10-K 2023-03-14
Q3 2022 29.9 M +365 K +1.24% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 29.7 M +168 K +0.57% Aug 4, 2022 10-Q 2022-08-11
Q1 2022 29.6 M +4.71 M +18.9% Mar 4, 2022 10-K 2022-03-10
Q3 2021 29.5 M +4.99 M +20.3% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 29.5 M +5.02 M +20.5% Aug 6, 2021 10-Q 2021-08-11
Q1 2021 24.9 M +532 K +2.19% Mar 4, 2021 10-K 2021-03-11
Q3 2020 24.6 M Nov 10, 2020 10-Q 2020-11-16
Q2 2020 24.5 M Aug 7, 2020 10-Q 2020-08-13
Q1 2020 24.3 M Mar 20, 2020 10-K 2020-03-30
Q4 2019 21.8 M Dec 6, 2019 10-Q 2019-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.